These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26873788)

  • 21. The complex world of oligodendroglial differentiation inhibitors.
    Kremer D; Aktas O; Hartung HP; Küry P
    Ann Neurol; 2011 Apr; 69(4):602-18. PubMed ID: 21520230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
    Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.
    Lin W; Bailey SL; Ho H; Harding HP; Ron D; Miller SD; Popko B
    J Clin Invest; 2007 Feb; 117(2):448-56. PubMed ID: 17273557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoting remyelination in multiple sclerosis: current drugs and future prospects.
    Kremer D; Küry P; Dutta R
    Mult Scler; 2015 Apr; 21(5):541-9. PubMed ID: 25623245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
    Chang A; Tourtellotte WW; Rudick R; Trapp BD
    N Engl J Med; 2002 Jan; 346(3):165-73. PubMed ID: 11796850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical localization of phosphorylated protein kinase R and phosphorylated eukaryotic initiation factor-2 alpha in the central nervous system of SJL mice with experimental allergic encephalomyelitis.
    Chakrabarty A; Danley MM; LeVine SM
    J Neurosci Res; 2004 Jun; 76(6):822-33. PubMed ID: 15160394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linkage between immunomodulation, neuroprotection and neurogenesis.
    Aharoni R; Arnon R
    Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
    Moll NM; Hong E; Fauveau M; Naruse M; Kerninon C; Tepavcevic V; Klopstein A; Seilhean D; Chew LJ; Gallo V; Nait Oumesmar B
    Glia; 2013 Oct; 61(10):1659-72. PubMed ID: 23918253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.
    Liblau R
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S17-23. PubMed ID: 20106343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular approaches for stimulating CNS remyelination.
    Miller RH; Bai L
    Regen Med; 2007 Sep; 2(5):817-29. PubMed ID: 17907933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target.
    Nakahara J; Aiso S; Suzuki N
    Expert Opin Ther Targets; 2009 Dec; 13(12):1375-86. PubMed ID: 19839715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cellular and molecular events of central nervous system remyelination.
    Dubois-Dalcq M; Armstrong R
    Bioessays; 1990 Dec; 12(12):569-76. PubMed ID: 2080911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The roles of protein kinase R-like ER kinase signal pathway in endoplasmic reticulum stress].
    Lv ZR; Liu XH
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):154-7. PubMed ID: 21770270
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanisms of tissue injury in multiple sclerosis: opportunities for neuroprotective therapy.
    Pouly S; Antel JP; Ladiwala U; Nalbantoglu J; Becher B
    J Neural Transm Suppl; 2000; (58):193-203. PubMed ID: 11128609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-mediated remyelination: relevance to multiple sclerosis.
    Bieber A; Asakura K; Warrington A; Kaveri SV; Rodriguez M
    Mult Scler; 2000 Oct; 6 Suppl 2():S1-5; discussion S33. PubMed ID: 11188771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis.
    Raine CS; Moore GR; Hintzen R; Traugott U
    Lab Invest; 1988 Oct; 59(4):467-76. PubMed ID: 2459499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.
    Wootla B; Watzlawik JO; Denic A; Rodriguez M
    Expert Rev Clin Immunol; 2013 Jun; 9(6):535-49. PubMed ID: 23730884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress.
    Lin W; Kemper A; Dupree JL; Harding HP; Ron D; Popko B
    Brain; 2006 May; 129(Pt 5):1306-18. PubMed ID: 16504972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of remyelination in multiple sclerosis.
    Hanafy KA; Sloane JA
    FEBS Lett; 2011 Dec; 585(23):3821-8. PubMed ID: 21443876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.